Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mitochondrial dysfunction and amyotrophic lateral sclerosis.

Isabel Hervias1, M Flint Beal, Giovanni Manfredi

  • 1Department of Neurology and Neuroscience, Weill Medical College of Cornell University, 525 East 68th Street, A-505, New York, New York 10021, USA.

Muscle & Nerve
|December 24, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and Prognostic Relevance of Cycle Pattern Recognition in Bipolar Disorder: A Further Step Toward Personalised Treatment Pathways?

Current neuropharmacology·2026
Same author

Pregnancy precipitates metabolic imbalance and accelerates death in an animal model of mitochondrial cardiomyopathy.

Molecular metabolism·2026
Same author

Lifetime Mixed Depression and Childhood Trauma in Individuals With Bipolar Disorders.

Acta psychiatrica Scandinavica·2026
Same author

Taming a Maxwell's demon for experimental stochastic resetting.

Physical review. E·2026
Same author

A mouse model of CHCHD10 p.R15L familial ALS presents mild, age-related motor neuron degeneration without protein instability or mitochondrial dysfunction.

bioRxiv : the preprint server for biology·2026
Same author

Investigation of mitochondrial phenotypes in motor neurons derived by direct conversion of fibroblasts from familial ALS subjects.

Cell death & disease·2025
Same journal

Fat-Fraction Quantification Using Three-Point Dixon Technique in Duchenne Muscular Dystrophy and Its Correlation With Clinical Progression and Genotypic Characteristics: A Single Centre One-Year Prospective Study.

Muscle & nerve·2026
Same journal

Characterizing Combined Central and Peripheral Demyelination-Insights From a Multimodal Comparison With Chronic Inflammatory Demyelinating Polyneuropathy and Multiple Sclerosis.

Muscle & nerve·2026
Same journal

Electrical Modalities in the Rehabilitation of Peripheral Nerve Injuries: State of the Literature and Current Clinical Applications.

Muscle & nerve·2026
Same journal

Reply to "Sural/Radial Amplitude Ratio in Non-Length-Dependent Neuropathy (NLDN): A Call for More Standardized Methodology and Further Evaluation of Distal NLDN".

Muscle & nerve·2026
Same journal

Late-Onset Myasthenia Gravis: An Increasingly Frequent Clinical Entity With Distinctive Challenges.

Muscle & nerve·2026
Same journal

Clinical Characteristics and Treatment Management of Seronegative Myasthenia Gravis: A Systematic Review of the Literature.

Muscle & nerve·2026
See all related articles

Mitochondrial dysfunction is implicated in amyotrophic lateral sclerosis (ALS) pathogenesis. Mutant superoxide dismutase (SOD1) in mitochondria may directly cause motor neuron death, offering potential therapeutic targets.

Area of Science:

  • Neuroscience
  • Genetics
  • Cell Biology

Background:

  • Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with unknown causes of motor neuron death.
  • Mitochondrial dysfunction is increasingly suspected in ALS pathogenesis, with observed abnormalities in patients and animal models.
  • Mutant superoxide dismutase (SOD1) is linked to familial ALS (FALS), and its role in mitochondrial damage is under investigation.

Purpose of the Study:

  • To investigate the role of mitochondrial dysfunction in ALS pathogenesis.
  • To explore the mechanisms by which mutant SOD1 may damage mitochondria.
  • To identify potential therapeutic targets for ALS based on mitochondrial involvement.

Main Methods:

  • Analysis of postmortem spinal cords from ALS patients.

Related Experiment Videos

  • Examination of mitochondrial abnormalities in transgenic mice expressing mutant SOD1.
  • Investigating the localization and aggregation of mutant SOD1 within mitochondria.

    • Main Results:

    • Biochemical and morphological mitochondrial abnormalities are present in ALS patients.
    • Mitochondrial dysfunction precedes disease onset in SOD1-mutant mice, suggesting a causal role.
    • Mutant SOD1 localizes to mitochondria and forms aggregates, supporting direct mitochondrial damage hypothesis.

    Conclusions:

    • Mitochondrial dysfunction is a significant factor in ALS pathogenesis, particularly in SOD1-related forms.
    • Mutant SOD1 may directly damage mitochondria, leading to motor neuron death.
    • Targeting mitochondrial dysfunction presents a promising therapeutic strategy for ALS.